Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Acazicolcept 💬[1] Acazicolcept (Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways)[1] Acazicolcept[2] CD28,
ICOS 💬
[13] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis 💬[1] 49 💬
2 Batiraxcept 💬[1] Batiraxcept (Axl fc fusion protein avb-s6-500)[1] AVB-S6-500[1] AXL 💬 [1] Efferocytosis 💬[1] 66 💬
3 Efavaleukin alfa 💬[1] Efavaleukin alfa (Fc il-2 mutein fusion protein)[1] Efavaleukin alfa--[2] 49, 97 💬
4 Efzofitimod 💬[1] Efzofitimod (Human IgG1Fc- iMod domain of human HARS fusion protein)[1] Efzofitimod[2] HARS,
HARS 💬
[1] Aminoacyl-tRNA biosynthesis 💬[1] 84 💬